Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data

EJNMMI Research

Volumn 2, Issue 1, 2012, Pages 1-8

  Contractor, Kaiyumars B ^a   Kenny, Laura M ^a   Coombes, Charles R ^a   Turkheimer, Federico E ^b   Aboagye, Eric O ^a   Rosso, Lula ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

FLT; Input function; Kinetic modelling; Quantification; Tumour proliferation

Indexed keywords

3' FLUOROTHYMIDINE F 18;

AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CORRELATIONAL STUDY; HUMAN; ISOTOPE LABELING; METABOLITE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; STEADY STATE; TEST RETEST RELIABILITY; TUMOR GROWTH; VALIDATION PROCESS;

EID: 84875912267     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-2-11     Document Type: Article

References (28)

1. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al: Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998, 4(11):1334-1336.
2. Rudin M: Molecular Imaging-Basic Principles and Applications in Biomedical Research London: Imperial College Press; 2005.
3. Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al: Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med 2003, 44(9):1426-1431.
4. Ullrich R, Backes H, Li H, Kracht L, Miletic H, Kesper K, et al: Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clin Cancer Res 2008, 14:2049-2055.
5. Kenny LM, Vigushin DM, Al-Nahhas A, Osman S, Luthra SK, Shousha S, et al: Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [F-18]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods. Cancer Res 2005, 65(21):10104-10112.
6. Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, et al: Molecular imaging of proliferation in malignant lymphoma. Cancer Res 2006, 66(22):11055-11061.
7. Mourik JEM, van Velden FHP, Lubberink M, Kloet RW, van Berckel BNM, Lammertsma AA, et al: Image derived input functions for dynamic high resolution research tomograph PET brain studies. Neuroimage 2008, 43(4):676-686.
8. Germano G, Chen BC, Huang SC, Gambhir SS, Hoffman EJ, Phelps ME: Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. J Nucl Med 1992, 33(4):613-620.
9. Watabe H, Channing MA, Riddell C, Jousse F, Libutti SK, Carrasquillo JA, et al: Noninvasive estimation of the aorta input function for measurement of tumor blood flow with. IEEE Trans Med Imaging 2001, 20(3):164-174.
10. Asselin MC, Cunningham VJ, Amano S, Gunn RN, Nahmias C: Parametrically defined cerebral blood vessels as non-invasive blood input functions for brain PET studies. Phys Med Biol 2004, 49(6):1033-1054.
11. Zanotti-Fregonara P, Fadaili EM, Maroy R, Comtat C, Souloumiac A, Jan S, et al: Comparison of eight methods for the estimation of the imagederived input function in dynamic [(18)F]-FDG PET human brain studies. J Cereb Blood Flow Metab 2009, 29(11):1825-1835.
12. Sundaram SK, Freedman NMT, Carrasquillo JA, Carson JM, Whatley M, Libutti SK, et al: Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach. J Nucl Med 2004, 45(8):1328-1333.
13. Bentourkia M: Kinetic modeling of PET data without blood sampling. IEEE 2005, 52(3):697-702.
14. Shields AF, Briston DA, Chandupatla S, Douglas KA, Lawhorn-Crews J, Collins JM, et al: A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention. Eur J Nucl Med Mol Imaging 2005, 32(11):1269-1275.
15. Cook GJ, Lodge MA, Marsden PK, Dynes A, Fogelman I: Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med 1999, 26(11):1424-1429.
16. Takikawa S, Dhawan V, Spetsieris P, Robeson W, Chaly T, Dahl R, et al: Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993, 188(1):131-136.
17. Eberl S, Anayat AR, Fulton RR, Hooper PK, Fulham MJ: Evaluation of two population-based input functions for quantitative neurological FDG PET studies. Eur J Nucl Med 1997, 24(3):299-304.
18. Kissel J, Port RE, Zaers J, Bellemann ME, Strauss LG, Haberkorn U, et al: Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach. Med Phys 1999, 26(4):609-615.
19. Kim SJ, Lee JS, Im KC, Kim SY, Park SA, Lee SJ, et al: Kinetic modeling of 3 '-deoxy-3 '-F-18-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. J Nucl Med 2008, 49(12):2057-2066.
20. Menda Y, Ponto LLB, Dornfeld KJ, Tewson TJ, Watkins GL, Schultz MK, et al: Kinetic analysis of 3 '-deoxy-3 '-F-18-fluorothymidine (F-18-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy. J Nucl Med 2009, 50(7):1028-1035.
21. Visvikis D, Francis D, Mulligan R, Costa DC, Croasdale I, Luthra SK, et al: Comparison of methodologies for the in vivo assessment of (FLT)-F-18 utilisation in colorectal cancer. Eur J Nucl Med Mol Imaging 2004, 31(2):169-178.
22. de Langen AJ, Klabbers B, Lubberink M, Boellaard R, Spreeuwenberg MD, Slotman BJ, et al: Reproducibility of quantitative F-18-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography. Eur J Nucl Med Mol Imaging 2009, 36(3):389-395.
23. Backes H, Ullrich R, Neumaier B, Kracht L, Wienhard K, Jacobs AH: Noninvasive quantification of F-18-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Eur J Nucl Med Mol Imaging 2009, 36(12):1960-1967.
24. Kenny L, Coombes RC, Vigushin DM, Al-Nahhas A, Shousha S, Aboagye EO: Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F] fluorothymidine positron emission tomography. Eur J Nucl Med Mol Imaging 2007, 34(9):1339-1347.
25. Coleman TF, Li Y: On the convergence of reflective Newton methods for large-scale nonlinear minimization subject to bounds. 1994, 67(2):189-224.
26. Coleman TF, Li Y: An interior, trust region approach for nonlinear minimization subject to bounds. SIAM J Optim 1996, 6:418-445.
27. Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, Krohn KA: Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. J Nucl Med 2005, 46(2):371-380.
28. Mankoff DA, Shields AF, Graham MM, Link JM, Krohn KA: A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites. J Nucl Med 1996, 37(12):2049-2057.